AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Yervoy has 59.3 points more BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: Yervoy (yervoy.com)
A total technical blackout that provides zero substance behind the pharmaceutical signal of the domain name. This is a digital void where there should be clinical evidence, resulting in a maximum BS score due to the total absence of promised content. The site is currently a non-entity in terms of business communication.
Resolve the server-side credential issues and remove the 403 Forbidden status to allow content to be indexed. Populate the homepage with specific FDA approval numbers and links to published ClinicalTrials.gov results. Implement robust Organization and MedicalEntity schema to verify the brand’s identity and authority. Replace generic server error messages with a clear navigation hierarchy including ‘Clinical Data’ and ‘Prescribing Information’.
The Information Density is effectively zero as the site contains no specific nouns, numbers, or industry-specific data. The text is 100% saturated with server error codes like ‘403 – Forbidden’ and generic error descriptions. There are no instances of specific evidence, resulting in the maximum possible penalty for specificity absence.
AI only sees the HTML that arrives on first response — everything else is invisible. Expose your real text only footprint and find out which parts of your site never reach an AI crawler at all.
The drift is absolute; the URL suggests a brand-specific destination, but the landing page delivers a ‘Server Error’. There is a total disconnect between the primary signal of the domain name and the actual substance provided to the user. No sub-pages were accessible to evaluate messaging consistency, confirming a total breakdown of the communication hierarchy.
Stop the ROI leak caused by technical debt and strategic misalignment. Conduct an Independent Strategic Diagnosis for 1 Euro to identify high impact issues across all audit categories.
With a review_count of 0 and a proof_links_count of 0, the site provides no external validation or path for verification. The absence of any trust indicators on a page claiming to be part of a regulated industry creates a total vacuum of credibility. There is no evidence of FDA clearance, clinical trials, or peer-reviewed studies as required by the industry pattern dictionary.
The ratio of verifiable evidence to unsubstantiated claims is 0:0, which in a forensic audit equates to a total failure of proof. The crawl returned zero proof points, zero citations, and zero regulatory identifiers. The site provides 145 characters of text, all of which are dedicated to access denial rather than clinical substance.
To review a full competitive diagnostic applied to an enterprise level technical SEO agency, including a direct comparison against Dejan, examine the complete executive audit. View the iPullRank Executive SEO Strategy Dashboard for a practical example of how perception gaps, value prop drift, and audience misalignment are surfaced in real audits.
The content is the ultimate commodity: a generic server error template that could be found on any non-functioning website regardless of industry. It contains none of the template_fingerprints such as ‘Clinical Data’ or ‘Patient Resources’ expected for a pharma site. The value proposition is non-existent, replaced by boilerplate technical rejection text.
There is no schema_json present to establish organizational identity or expert authority. The technical implementation is critically flawed, showing a massive technical credibility gap for a company positioned in a high-stakes medical field. No named experts or technical specifications are available to verify authority.
The site fails to demonstrate any performance because it is inaccessible. While it does not make verbal claims, the technical failure suggests a lack of the ‘world-class research and development’ or ‘science-driven solutions’ typically claimed in the biotech sector. There are no case studies, results, or clinical outcomes provided.
Medical Devices, Pharma & Biotech BS: Yervoy (yervoy.com)
While the industry classification is Medical Devices, Pharma & Biotech, the site content provides zero technical or clinical confirmation. The evidence consists solely of a 403 Forbidden error, which completely fails to align with the expected substance of a pharmaceutical or biotech entity.
A page that loads perfectly for users can still return an empty shell to an AI crawler. Examine the Crawlability Technical Guide and understand why script free extraction is the real measure of visibility.
“The score of 100 is a direct result of the site providing zero information across all pillars. The Information Density and Trust and Proof pillars reached maximum point values because the website failed to present a single piece of evidence, claim, or identity marker. This represents the highest possible distance between a brand's URL 'Signal' and its visible 'Substance'.”